2-23971290-G-T

Variant summary

Our verdict is Uncertain significance. Variant got 0 ACMG points: 2P and 2B. PM2BP4_Moderate

The NM_181713.4(UBXN2A):​c.56G>T​(p.Gly19Val) variant causes a missense change. The variant allele was found at a frequency of 0.000397 in 1,564,280 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).

Frequency

Genomes: 𝑓 0.00028 ( 0 hom., cov: 32)
Exomes 𝑓: 0.00041 ( 0 hom. )

Consequence

UBXN2A
NM_181713.4 missense

Scores

6
13

Clinical Significance

Uncertain significance criteria provided, single submitter U:1

Conservation

PhyloP100: 4.43
Variant links:
Genes affected
UBXN2A (HGNC:27265): (UBX domain protein 2A) Predicted to enable ubiquitin binding activity. Predicted to be involved in several processes, including autophagosome assembly; nuclear membrane reassembly; and proteasome-mediated ubiquitin-dependent protein catabolic process. Predicted to act upstream of or within cellular response to leukemia inhibitory factor; regulation of gene expression; and regulation of protein metabolic process. Predicted to be located in cis-Golgi network and endoplasmic reticulum. Predicted to be active in cytosol and nucleus. [provided by Alliance of Genome Resources, Apr 2022]

Genome browser will be placed here

ACMG classification

Classification made for transcript

Verdict is Uncertain_significance. Variant got 0 ACMG points.

PM2
Very rare variant in population databases, with high coverage;
BP4
Computational evidence support a benign effect (MetaRNN=0.0838936).

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect #exon/exons MANE UniProt
UBXN2ANM_181713.4 linkuse as main transcriptc.56G>T p.Gly19Val missense_variant 3/7 ENST00000309033.5

Ensembl

Gene Transcript HGVSc HGVSp Effect #exon/exons TSL MANE Appris UniProt
UBXN2AENST00000309033.5 linkuse as main transcriptc.56G>T p.Gly19Val missense_variant 3/71 NM_181713.4 P1P68543-1
UBXN2AENST00000446425.2 linkuse as main transcriptn.518G>T non_coding_transcript_exon_variant 4/81
UBXN2AENST00000404924.5 linkuse as main transcriptc.56G>T p.Gly19Val missense_variant 4/82 P1P68543-1

Frequencies

GnomAD3 genomes
AF:
0.000283
AC:
43
AN:
152106
Hom.:
0
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.000121
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.00
Gnomad ASJ
AF:
0.00260
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.00
Gnomad FIN
AF:
0.00
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.000426
Gnomad OTH
AF:
0.00
GnomAD3 exomes
AF:
0.000259
AC:
64
AN:
246704
Hom.:
0
AF XY:
0.000263
AC XY:
35
AN XY:
133128
show subpopulations
Gnomad AFR exome
AF:
0.000123
Gnomad AMR exome
AF:
0.00
Gnomad ASJ exome
AF:
0.00170
Gnomad EAS exome
AF:
0.00
Gnomad SAS exome
AF:
0.00
Gnomad FIN exome
AF:
0.00
Gnomad NFE exome
AF:
0.000390
Gnomad OTH exome
AF:
0.000166
GnomAD4 exome
AF:
0.000409
AC:
578
AN:
1412174
Hom.:
0
Cov.:
30
AF XY:
0.000392
AC XY:
272
AN XY:
694128
show subpopulations
Gnomad4 AFR exome
AF:
0.0000610
Gnomad4 AMR exome
AF:
0.0000694
Gnomad4 ASJ exome
AF:
0.00166
Gnomad4 EAS exome
AF:
0.00
Gnomad4 SAS exome
AF:
0.0000127
Gnomad4 FIN exome
AF:
0.0000191
Gnomad4 NFE exome
AF:
0.000471
Gnomad4 OTH exome
AF:
0.000344
GnomAD4 genome
AF:
0.000283
AC:
43
AN:
152106
Hom.:
0
Cov.:
32
AF XY:
0.000242
AC XY:
18
AN XY:
74294
show subpopulations
Gnomad4 AFR
AF:
0.000121
Gnomad4 AMR
AF:
0.00
Gnomad4 ASJ
AF:
0.00260
Gnomad4 EAS
AF:
0.00
Gnomad4 SAS
AF:
0.00
Gnomad4 FIN
AF:
0.00
Gnomad4 NFE
AF:
0.000426
Gnomad4 OTH
AF:
0.00
Alfa
AF:
0.000461
Hom.:
0
Bravo
AF:
0.000264
TwinsUK
AF:
0.000270
AC:
1
ALSPAC
AF:
0.000778
AC:
3
ESP6500AA
AF:
0.00
AC:
0
ESP6500EA
AF:
0.000465
AC:
4
ExAC
AF:
0.000255
AC:
31

ClinVar

Significance: Uncertain significance
Submissions summary: Uncertain:1
Revision: criteria provided, single submitter
LINK: link

Submissions by phenotype

not specified Uncertain:1
Uncertain significance, criteria provided, single submitterclinical testingAmbry GeneticsMay 27, 2022The c.56G>T (p.G19V) alteration is located in exon 3 (coding exon 2) of the UBXN2A gene. This alteration results from a G to T substitution at nucleotide position 56, causing the glycine (G) at amino acid position 19 to be replaced by a valine (V). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.083
BayesDel_addAF
Benign
-0.28
T
BayesDel_noAF
Benign
-0.33
CADD
Uncertain
24
DANN
Uncertain
1.0
DEOGEN2
Benign
0.076
T;T
Eigen
Uncertain
0.21
Eigen_PC
Benign
0.21
FATHMM_MKL
Uncertain
0.88
D
LIST_S2
Benign
0.75
.;T
M_CAP
Benign
0.014
T
MetaRNN
Benign
0.084
T;T
MetaSVM
Benign
-0.87
T
MutationAssessor
Benign
1.7
L;L
MutationTaster
Benign
1.0
D;D;D
PrimateAI
Benign
0.40
T
PROVEAN
Uncertain
-2.4
N;N
REVEL
Benign
0.11
Sift
Uncertain
0.0030
D;D
Sift4G
Uncertain
0.037
D;D
Polyphen
0.99
D;D
Vest4
0.38
MVP
0.61
MPC
0.47
ClinPred
0.17
T
GERP RS
3.6
RBP_binding_hub_radar
0.0
RBP_regulation_power_radar
1.1
Varity_R
0.13
gMVP
0.51

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.010
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

LitVar

Below is the list of publications found by LitVar. It may be empty.

Other links and lift over

dbSNP: rs139718365; hg19: chr2-24194160; API